News

March 5, 2021March 5, 2021

Targeted Lung Denervation Found Effective, Safe Over 3 Years of Follow-up

News

Lung function and quality of life remained stable over three years of follow-up among people with chronic obstructive pulmonary disease (COPD) treated with targeted lung denervation (TLD) — a new ... Read more

March 2, 2021March 2, 2021

Foundations Merge to Do More for People With Lung Diseases

News

Two Montreal-based foundations are joining forces to boost research and care into complex and chronic respiratory disorders, including chronic obstructive pulmonary disease (COPD). The merging of the McGill University Health Centre ... Read more

February 25, 2021February 25, 2021

Partnership Brings Quantitative Imaging Analysis to Diagnosis, Care

News

A new collaboration is seeking to bring quantitative imaging analysis to diagnosis and care of patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD) and emphysema. The agreement ... Read more

February 23, 2021February 23, 2021

FDA OKs Pivotal Trial Testing RheOx System in Chronic Bronchitis

News

The U.S. Food and Drug Administration (FDA) has cleared the start of an international pivotal trial to test the RheOx System, Gala Therapeutics’ medical device, in adults with chronic obstructive ... Read more

February 18, 2021February 18, 2021

Weight Loss, Low BMI Tied to Worse Mortality in Japanese Men

News

Weight loss and a low body mass index (BMI) are associated with worse mortality outcomes among men with chronic obstructive pulmonary disease (COPD) in Japan, according to a new study. ... Read more

February 16, 2021February 16, 2021

New Algorithm May Find Misdiagnosis in COPD

News

A new algorithm-based approach was developed to identify patients at risk of being misdiagnosed with chronic obstructive pulmonary disease (COPD). Researchers believe this may become an important tool to help ... Read more

February 11, 2021February 11, 2021

Trixeo Aerosphere Approved in Scotland as COPD Maintenance Therapy

News

The Scottish Medicines Consortium (SMC) has approved AstraZeneca‘s triple combination therapy Trixeo Aerosphere as a maintenance treatment for chronic obstructive pulmonary disease (COPD). The approval specifically covers adults with moderate to severe ... Read more

February 9, 2021February 9, 2021

American Lung Association Awards $50K for Regenerative Medicine Project

News

As part of its Catalyst Grant program, the American Lung Association (ALA) has awarded $50,000 for a project aimed at regenerating damaged lung tissue. Researcher Ya-Wen Chen, PhD, hopes her ... Read more

February 4, 2021February 4, 2021

FDA Gives Green Light to Clinical Trial of Zofin

News

The U.S. Food and Drug Administration (FDA) has granted Organicell Regenerative Medicine permission to begin a clinical trial testing the company’s lead product, Zofin, in people with chronic obstructive pulmonary ... Read more

February 2, 2021February 2, 2021

Inhaled Hyaluronan Found to Ease Acute COPD Exacerbations

News

In a pilot Phase 2 study, inhaled hyaluronan — which uses sugar secreted by living tissue that acts as a scaffold for cells — treated people with acute exacerbations of chronic ... Read more